May 2011 (Vol. 10, No. 5)

Evidence-Based Reviews

Benzodiazepines and stimulants for patients with substance use disorders
Michael I. Casher, MD; Daniel Gih, MD; Joshua D. Bess, MD

Minimizing the impact of elevated prolactin in children and adolescents
Wynn W. Paing, MD; Ronald A. Weller, MD; Roomana Sheikh, MD; Elizabeth B. Weller, MD

Does your patient have a psychiatric illness or nonverbal learning disorder?
Sergio V. Delgado, MD; Elizabeth Wassenaar, MD; Jeffrey R. Strawn, MD

From The Editor

Parsimonious pharmacotherapy
Henry A. Nasrallah, MD

Cases That Test Your Skills

Depression or delirium?
Juan Carlos Cleves-Bayon, MD; Kirsten M. Wilkins, MD; Rajesh R. Tampi, MBBS

Comments & Controversies

Tx for pseudobulbar affect

More on hyperammonemia

TBI and growth hormone

Pearls

Reduce inpatient violence: 6 strategies
Daniel W. Hardy, MD, JD; Malini Patel, MD

Help patients SLEEP without medication
Richard C. Christensen, MD, MA; James C. Byrd, MD

Savvy Psychopharmacology

Abuse of second-generation antipsychotics: What prescribers need to know
Gregory T. Bogart, PharmD; Carol A. Ott, PharmD, BCPP

Subscribe to Current Psychiatry e-alert